
The reality TV star and certified obesity physician Dr. Holly Lofton plan to use the show to further educate GLP-1 users on potential side effects.

The reality TV star and certified obesity physician Dr. Holly Lofton plan to use the show to further educate GLP-1 users on potential side effects.

Alliance Pharmaceuticals plans to use the new to attack counterfeiters rather than just defend against them.

Leqselvi are currently available 8 mg tablets for severe Alopecia Areata treatments in adult patients.

LEO Pharma expected to expand Spevigo developments as well as improve access to care.

Bravecto Quantum becomes first FDA approved drug to protect dogs against fleas and ticks for 8 to 12 months.

rs6190 helps men build muscle mass and reduce diabetes risk, but increases cholesterol levels and elevates the risk of clogged arteries and heart disease in women.

The company will continue to experiment with microgravity-derived experiments.

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

The drug is currently in Phase 1 clinical trials for gastric cancer treatments.